Global Amoxicillin Market, By Drug Class (Penicillin, Cephalosporin, Tetracycline, Macrolides, Sulfonamides), Therapy Type (Monotherapy, Combinational Therapy), Indication (Respiratory Tract Infection, Skin Infection, Chest Infection, Ear Infection, Urinary Tract Infection, Bacterial Endocarditis, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Amoxicillin Market Analysis and Size
The global amoxicillin market is expected to witness significant growth during the forecast period. The wide use of amoxicillin among primary care physicians has been growing for treating a wide spectrum of common infections, notably acute respiratory infections, dental abscesses, ear infections, and stomach ulcers. This is used in those who have kidney problems, it is not harmful for pregnant women and also during breastfeeding. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global amoxicillin market in the forecast period 2022-2029. The expected CAGR of global amoxicillin market is tend to be around 2% in the mentioned forecast period. The market was valued at USD 4.7 billion in 2021, and it would grow upto USD 5.51 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Amoxicillin commercialized under the brand name of Amoxil, Moxatag, and Larotid is a penicillin antibiotic widely used in treating respiratory tract infection. It acts as bactericidal as it hinders the cell wall biosynthesis of the bacteria. It is an antibiotic that is often used for the treatment of a number of bacterial infections. It may be used for skin infections, middle ear infection, strep throat, pneumonia, and urinary tract infections among others. It is mostly taken by mouth, or less commonly by injection.
Amoxicillin Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Drug Class (Penicillin, Cephalosporin, Tetracycline, Macrolides, Sulfonamides), Therapy Type (Monotherapy, Combinational Therapy), Indication (Respiratory Tract Infection, Skin Infection, Chest Infection, Ear Infection, Urinary Tract Infection, Bacterial Endocarditis, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Pfizer Inc (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb Company (U.S.), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Mylan N.V. (U.S.), Novartis AG (Switzerland), Lupin (India), Cipla Inc (India), Aurobindo Pharma (India), Zydus Group (India), Wockhardt (India)
|
|
Market Opportunities
|
|
Global Amoxicillin Market Dynamics
Drivers
- Increased Understanding of Antibiotics
The rising understanding of the common harms of antibiotics is a primary trend that is shaping the contours of demand in the amoxicillin market. Several pharmaceutical companies have gained from the increasing array of the approved indications by the U.S. FDA for amoxicillin. Some of them are Helicobacter pylori eradication, ear, nose, and throat infections, lower respiratory tract infections, and acute bacterial sinusitis. Thus, it boosts the market growth.
- Higher Pace of Research Activities and Developments
Amoxicillin has proven to be safe in use in pregnant women and nursing mothers. Regulatory agencies are inclined to update the guidelines eventually in the light of emerging evidence. Some of the common ones are hypersensitivity reactions, nephrotoxicity, and hepatotoxicity. Several ongoing studies on postmarketing adverse drug reactions are expected to shape the future growth courses of the amoxicillin market.
Opportunities
- Growing Impaired Renal Function
The increasing patients with impaired renal function is a main trend strengthening the opportuities in the amoxicillin market. The rapidly aging population in highly developing countries is boosting market expansion growth. The rising occurrence of urinary tract infections among women is also creating expansion for the amoxicillin market expansion.
- Prevalence of Lower Respiratory Infections
Lower respiratory tract infections have encouraged the demand for products in the amoxicillin market. In community-acquired pneumonia, it is widely used in combination of macrolide. Skin infections that is caused due to Streptococcus species, Staphylococcus species, and Escherichia coli boosts a substantial avenue.
Restraints/Challenges
- Side Effects of Amoxicillin
There are several adverse effects that are related with amoxicillins that hamper the growth of the market. Effect such as black, tarry stools, bloody nose, chest pain, back, leg, or stomach pains, bloating, blood in the urine hamper the market growth.
- High Cost
The huge expenditure associated with the production and development phases of these amoxicillins surely hamper the market growth.
- Lack of Proper Medication
Lack of appropriate medications and treatment is expected to increase this medical condition's effects. According to the market analysis, less awareness can lead to a small adoption rate of amoxicillin. Thus, these factors can restrict the total demand for the olanzapine market during the forecast period.
This global amoxicillin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global amoxicillin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Amoxicillin Market
The huge infection rate and severe impact on public health systems has led numerous governments to reinforce nationwide lockdowns considerably impacting manufacturing supply chains, trade, and related services. The global impact of COVID-19 significantly affected the Amoxicillin market in 2020. The outbreak of COVID-19 led to travel bans and quarantines; uncertainty in the stock market; falling business confidence, and rising panic among the population. Despite the rising uncertainty and panic, technology suppliers should continue to focus on their long-term investments, maintain engagement with partners and prospects, and look to specific markets for stability.
Global Amoxicillin Market Scope
The global amoxicillin market is segmented on the basis of therapy type, indication, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Drug Class
- Penicillin
- Cephalosporin
- Tetracycline
- Macrolides
- Sulfonamides
Therapy Type
- Monotherapy
- Combinational Therapy
Indication
- Respiratory Tract Infection
- Skin Infection
- Chest Infection
- Ear Infection
- Urinary Tract Infection
- Bacterial Endocarditis
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Amoxicillin Market Regional Analysis/Insights
The global amoxicillin market is analysed and market size insights and trends are provided by therapy type, indication, distribution channel and end-user as referenced above.
The major countries covered in the global amoxicillin market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing the highest growth for the global amoxicillin market throughout the forecasted period due to the increase’s cases of cardiovascular diseases and rapidly aging population.
North America dominates the market due to the increase prevalence of respiratory infections and advanced healthcare facilities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Amoxicillin Market Share Analysis
The global amoxicillin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global amoxicillin market.
Key players operating in the global amoxicillin market include:
- Pfizer Inc (U.S.)
- AstraZeneca (U.K.)
- Bristol-Myers Squibb Company (U.S.)
- Dr. Reddy's Laboratories Ltd (India)
- Endo International plc (Ireland)
- Teva Pharmaceutical Industries Ltd (Israel)
- Sun Pharmaceutical Industries Ltd (India)
- Mylan N.V. (U.S.)
- Novartis AG (Switzerland)
- Lupin (India)
- Cipla Inc (India)
- Aurobindo Pharma (India)
- Zydus Group (India)
- Wockhardt (India)
SKU-